机构:[1]Department of Traditional Chinese Medicine, Affiliated Shenzhen Maternity & Child Healthcare Hospital,Southern Medical University, Shenzhen, China,南方医科大学深圳医院深圳市妇幼保健院深圳市康宁医院深圳医学信息中心[2]Research Center of Allergy & Immunology, Shenzhen University School of Medicine, Shenzhen, China,[3]Department of Respirology, Affiliated Hospital of XinanMedical University, Luzhou, China,[4]Department of Allergy, Longgang ENT Hospital & Shenzhen Key Laboratory of ENT, Institute of ENT, Shenzhen, China,深圳市康宁医院深圳市龙岗区耳鼻咽喉医院深圳医学信息中心[5]Department of Otolaryngology, Longgang Central Hospital, Shenzhen, China,深圳市康宁医院深圳医学信息中心[6]Guangdong Provincial Key Laboratory of Regional Immunity and Diseases,Shenzhen, China
Radiotherapy is one of the major remedies for the treatment of cancer, including nasopharyngeal carcinoma (NPC). Radioresistance occurs very often in target cells that is a large drawback in cancer treated with radiotherapy. Livin involves the over-growth of cancer cells. This study aims to investigate the role of livin in the radioresistance formation in NPC cells.
NPC cell lines were exposed to small doses of irradiation to establish a cell model of radioresistance, in which the role of livin in the development of radioresistance was evaluated.
The expression of livin was observed in NPC cells, which was significantly increased after exposing to small doses of irradiation. A negative correlation was detected between livin and Fas expression in NPC cells. Livin formed a complex with heat shock factor-1 (HSF1, the transcription factor of Fas) in NPC cells after irradiation, which sped up ubiquitination of HSF1. Livin was involved in suppressing Fas expression in NPC cells with radioresistance. Exposure to livin inhibitors prevented radioresistance development and overcame the established radioresistance in NPC cells.
Livin expression in NPC cells plays a critical role in the development of radioresistance. Depletion of livin increases the sensitiveness of NPC cells to irradiation. Target therapy against livin may have the translational potential for the treatment of NPC.
基金:
This study was supported by grants from
the National Nature and Science Foundation of
China (81870706, 31570932, 81700888,
81701589), Guangdong Provincial Key Laboratory
of Regional Immunity and Diseases
(2019B030301009) and the Shenzhen Science,
Technology and Innovation Committee
(JCYJ20170307162827158,
KQTD20170331145453160)
第一作者机构:[1]Department of Traditional Chinese Medicine, Affiliated Shenzhen Maternity & Child Healthcare Hospital,Southern Medical University, Shenzhen, China,[2]Research Center of Allergy & Immunology, Shenzhen University School of Medicine, Shenzhen, China,
通讯作者:
通讯机构:[2]Research Center of Allergy & Immunology, Shenzhen University School of Medicine, Shenzhen, China,[6]Guangdong Provincial Key Laboratory of Regional Immunity and Diseases,Shenzhen, China
推荐引用方式(GB/T 7714):
Ma Fei,Gu Xia,Liu Jiang-Qi,et al.Inhibition of livin overcomes radioresistance in nasopharyngeal carcinoma cells.[J].PLOS ONE.2020,15(3):doi:10.1371/journal.pone.0229272.
APA:
Ma Fei,Gu Xia,Liu Jiang-Qi,Mo Li-Hua,Yang Gui...&Yang Ping-Chang.(2020).Inhibition of livin overcomes radioresistance in nasopharyngeal carcinoma cells..PLOS ONE,15,(3)
MLA:
Ma Fei,et al."Inhibition of livin overcomes radioresistance in nasopharyngeal carcinoma cells.".PLOS ONE 15..3(2020)